It is also worth highlighting that when parkinsonism is the only core clinical feature of DLB in a patient with dementia, reduced DAT uptake as indicative biomarkers warrants a probable DLB diagnosis [3]. The gene discussed is SLC6A3; the disease is Parkinson disease.